Medical Advisory & Clinical Review Council
All disease overviews, cellular mechanism explanations, outcome expectations, and cost guides are reviewed by licensed medical professionals registered with the National Medical Commission (NMC) of India.
Our 4-Stage Fact-Checking & Review Protocol
Primary Biomedical Research
All clinical articles originate strictly from peer-reviewed literature indexed on PubMed, NCBI, ClinicalTrials.gov, and official guidelines published by the International Society for Stem Cell Research (ISSCR).
Specialist Clinician Audit
Neurologists, hematologists, and orthopedic specialists evaluate draft materials to verify cellular biological mechanisms, route safety (IV/intrathecal), dosage accuracy, and realistic symptom endpoints.
Statutory Regulatory Vetting
Content is audited against the National Guidelines for Stem Cell Research promulgated by the Indian Council of Medical Research (ICMR) and CDSCO ethical rules governing investigational cellular medicine.
Bi-Annual Re-Verification
Pages undergo bi-annual scheduled audits. When Phase I/II clinical trials publish updated safety or efficacy findings, pages are refreshed and timestamped with a new review date.
What We Never Claim vs What We Clinically Guarantee
In strict adherence to Google YMYL standards and medical tourism ethics, we enforce complete transparency:
Prohibited Content (What We Never Claim)
- × No "100% Miracle Cures": We never claim cellular therapy will permanently cure genetic or end-stage diseases.
- × No False Regulatory Status: We never disguise investigational protocols as standard proven treatments.
- × No Treatment Without Screening: We never accept a patient without rigorous diagnostic MRI/blood evaluation.
- × No Hidden Hospital Costs: We never publish artificially low teaser rates with surprise hospital bills.
Enforced Standards (What We Guarantee)
- ✓ Realistic Clinical Endpoints: Focusing on neuro-protection, motor preservation, and quality of life.
- ✓ ICMR & IEC Oversight: Explicitly detailing institutional ethics committee protocols.
- ✓ Transparent Indicative Pricing: Clear multisession starting packages from $4,000 USD.
- ✓ Laboratory Certificate of Analysis: Flow cytometry viability and sterility testing release documentation.
Evidence Hierarchy & Acceptable Biomedical Citations
Our editorial contributors prioritize data from high-impact medical journals and statutory regulatory agencies:
Medical Journals
The Lancet, Nature Medicine, Stem Cells Translational Medicine, Journal of Neurology.
Statutory Guidelines
ICMR National Guidelines (2017), CDSCO Clinical Trial Rules, US FDA CBER Guidance.
Global Registries
ClinicalTrials.gov (NIH/NLM), WHO International Clinical Trials Registry Platform (ICTRP).
Editorial Feedback & Correction Requests
We actively welcome peer review, physician feedback, and patient inquiries. If you identify any outdated trial citation, statistical ambiguity, or clinical discrepancy on our website, please notify our editorial board:
Clinical Case Review
Request a complimentary diagnostic evaluation by our multi-specialty medical review board.
Patient Guidance Hotline
Need guidance on diagnostic reports or treatment candidacy? Connect directly on WhatsApp.
WhatsApp: +91-7744005984